Genetic Testing in Prostate Cancer Webcast (2021)

Genetic Testing in Prostate Cancer: Understanding Clinical Implications for Early Detection, Localized Disease, & Castration Resistant Prostate Cancer Webcast (2021)

At the conclusion of this course, participants will be able to:
1. Counsel men with BRCA1/2 mutations, Lynch syndrome, and other key inherited syndromes regarding their prostate cancer risk and appropriate strategies for cancer screening.
2. Identify the criteria for genetic testing of prostate cancer patients, the gene panels available, and options for testing these men.
3. Interpret results of genetic testing and relay this information to patients in order to facilitate shared-decision making based on the test results.
4. Utilize the results of genetic testing to improve outcomes among patients with metastatic prostate cancer, including recommendations regarding PARP-inhibition, chemotherapy, and immunotherapy.

ACKNOWLEDGEMNTS
Independent educational grant support provided by:
Amgen
Astellas
AstraZeneca
Bristol-Myers Squibb
Exact Sciences Corporation
Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC
Merck
Pfizer, Inc.
Sanofi Genzyme